In opposition to the notion that activated AhR exacerbates hallmarks of NAFLD and genetic or pharmacological inhibition of AhR protects against fatty liver disease, recent studies have indicated the hepatoprotective role of induced AhR signaling in NAFLD models. Here, AHR is linked to fatty liver disease.